Renovascular hypertension associated with JAK2 V617F positive myeloproliferative neoplasms treated with angioplasty: 2 cases and literature review
- 14 April 2018
- journal article
- review article
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 20 (4) , 798-804
Abstract
Myeloproliferative neoplasms (MPNs) with Janus kinase 2 (JAK2) mutation are associated with a high risk for occlusive vascular diseases. We report 2 cases of renovascular hypertension associated with JAK2 V617F mutation‐positive MPNs and provide a literature review. In Case 1, a 63‐year‐old woman had resistant hypertension, massive proteinuria, and erythrocytosis. Evaluations revealed right renal artery stenosis causing renovascular hypertension and polycythemia vera with JAK2 V617F mutation. Renin‐angiotensin system inhibitors and subsequent angioplasty controlled the blood pressure and the proteinuria resolved. In Case 2, a 74‐year‐old woman had resistant hypertension and thrombocytosis. Evaluations confirmed left renal artery stenosis and essential thrombocythemia with JAK2 V617F. Angioplasty cured the hypertension. A literature review of 18 cases revealed the following as the most common characteristics of MPN‐associated renovascular hypertension: manifests primarily in women; is associated with untreated polycythemia vera and essential thrombocythemia, concomitant leukocytosis, and JAK2 mutation positivity; and is responsive to angioplasty. This report demonstrates that JAK2 mutation‐positive MPNs are a less common but important underlying cause of adult renovascular hypertension.Keywords
This publication has 26 references indexed in Scilit:
- Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international studyLeukemia, 2013
- Myeloproliferative neoplasms cause glomerulopathyKidney International, 2011
- A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complicationsLeukemia, 2010
- Revascularization versus Medical Therapy for Renal-Artery StenosisNew England Journal of Medicine, 2009
- Early renal arterial stent thrombosis associated with the JAK2 V617F mutationLeukemia Research, 2009
- A Gain-of-Function Mutation ofJAK2in Myeloproliferative DisordersNew England Journal of Medicine, 2005
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005
- Renovascular Hypertension with Massive Proteinuria.Internal Medicine, 1996
- Hypertension Complicating Essential ThrombocythemiaThe American Journal of the Medical Sciences, 1988
- Reno-vascular disease in polycythaemia rubra veraPostgraduate Medical Journal, 1983